KR890017259A - 모액으로부터의 항생물질 회수방법 및 그의 약학적으로 허용할 수 있는 신규한 염 - Google Patents

모액으로부터의 항생물질 회수방법 및 그의 약학적으로 허용할 수 있는 신규한 염 Download PDF

Info

Publication number
KR890017259A
KR890017259A KR1019890006240A KR890006240A KR890017259A KR 890017259 A KR890017259 A KR 890017259A KR 1019890006240 A KR1019890006240 A KR 1019890006240A KR 890006240 A KR890006240 A KR 890006240A KR 890017259 A KR890017259 A KR 890017259A
Authority
KR
South Korea
Prior art keywords
chloro
carboxylic acid
dethia
carba
cepem
Prior art date
Application number
KR1019890006240A
Other languages
English (en)
Other versions
KR0135979B1 (ko
Inventor
로웰 엔젤 게리
로버트 훼이퍼 랄프
Original Assignee
메리 앤 터커
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 메리 앤 터커, 일라이 릴리 앤드 캄파니 filed Critical 메리 앤 터커
Publication of KR890017259A publication Critical patent/KR890017259A/ko
Application granted granted Critical
Publication of KR0135979B1 publication Critical patent/KR0135979B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/02—Preparation
    • C07D463/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

내용 없음

Description

모액으로부터의 항생물질 회수방법 및 그의 약학적으로 허용할 수 있는 신규한 염
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (8)

  1. 안트라퀘논-1,5-디설폰산 또는 그의 알칼리 금속염을 일반식(Ⅱ) 화합물의 희석 수용액에 첨가하고 ; pH 를 약 1.0 내지 약 2.5로 조절함을 포함하는 일반식(Ⅰ)의 염의 제조방법.
    상기식에서, X는 황 또는 -CH2-이고 ; Y는 클로로이고 ; R은 수소, 하이드록시 또는 (C1내지 C4알킬)-S02NH-이다.
  2. 제 1 항에 있어서, R이 수소인 방법.
  3. 제 1 항에 있어서, R이 (C1내지 C4알킬)-SO2-NH-인 방법.
  4. 일반식(Ⅰ)의 화합물.
    상기식에서, X는 황 또는 -CH2-이고 ; Y는 클로로이고 , R은 수소, 하이드록시 또는 (C1내지 C4알킬)-S02NH-이다.
  5. 7β-(D-페닐글리실아미노)-3-클로로-1-카바(데티아)-3-세펨-4-카복실산, 7β-(D-페닐글리실아미노)-3-클로로-3-세펨-4-카복실산, 7β-(D-p-하이드록시페닐글리실아미노)-1-카바(1-데티아)-3-클로로-3-세펨-4-카복실산, 7β-(D-m-에틸설포닐아미노페닐글리실아미노)-1-카바(1-데티아)-3-클로로-3-세펨-4-카복실산, 및 7β-(D-m-메틸설포닐아미노페닐글리실아미노)-1-카바(1-데티아)-3-클로로-3-세펨-4-카복실산중 어느 한 화합물의 안트라퀴논-1,5-디설포네이트 염.
  6. 제 4 항에서 청구한 바와 같은 일반식(Ⅰ) 화합물의 항균제로의 용도.
    상기식에서, X는 황 또는 -CH2- 이고 ; Y는 클로로이고 ; R은 수소, 하이드록시 또는 (C1내지 C4알킬)-SO2NH-이다.
  7. 항균제로 사용하기 위한 7β-(D-페닐글리실아미노)-3-클로로-1-카바(데티아)-3-세펨-4-카복실산, 7β-(D-페닐글리실아미노)-3-클로로-3-세펨-4-카복실산, 7β-(D-p-하이드록시페닐글리실아미노)-1-카바(1-데티아)-3-세펨-4-카복실산, 7β-(D-m-에틸설포닐아미노페닐아미노페닐글리실아미노)-1-카바(1-데티아)-3-클로로-3-세펨-4-카복실산, 및 7β-(D-m-메틸실포닐아미노페닐글리실아미노)-1-카바(1-데티아)-3-클로로-세펨-4-카복실산중 어느 한 화합물의 안트라퀴논-1,5-디설포네이트 염.
  8. 활성 성분으로 제 4 항 또는 5항에서 청구한 바와 같은 일반식(Ⅰ) 화합물과 그의 약학적으로 허용할 수 있는 하나이상의 담체를 함께 포함하는 약학적 제제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890006240A 1988-05-13 1989-05-10 모액으로부터의 항생물질 회수방법 및 그의 약학적으로 허용할 수 있는 신규한 염 KR0135979B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19347488A 1988-05-13 1988-05-13
US193474 1988-05-13

Publications (2)

Publication Number Publication Date
KR890017259A true KR890017259A (ko) 1989-12-15
KR0135979B1 KR0135979B1 (ko) 1998-04-25

Family

ID=22713792

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890006240A KR0135979B1 (ko) 1988-05-13 1989-05-10 모액으로부터의 항생물질 회수방법 및 그의 약학적으로 허용할 수 있는 신규한 염

Country Status (5)

Country Link
EP (1) EP0341991A3 (ko)
JP (1) JPH0215078A (ko)
KR (1) KR0135979B1 (ko)
HU (1) HU203761B (ko)
IL (1) IL90269A (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5434259A (en) * 1993-02-05 1995-07-18 Eli Lilly And Company Process for isolation of cefaclor after enzymatic acylation
US5412094A (en) * 1993-06-28 1995-05-02 Eli Lilly And Company Bicyclic beta-lactam/paraben complexes
US6001996A (en) * 1995-05-11 1999-12-14 Eli Lilly And Company Complexes of cephalosporins and carbacephalosporins with parabens
US6362410B1 (en) 1999-09-28 2002-03-26 Kabushiki Kaisha Kawai Gakki Seisakusho Electronic musical instrument

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3676434A (en) * 1970-07-29 1972-07-11 Lilly Co Eli Cephalosporin salts
US3925372A (en) * 1973-02-23 1975-12-09 Lilly Co Eli Alpha-aminoacyl-3-halo cephalosporins
JPS608296A (ja) * 1983-06-29 1985-01-17 ユング・ジン・フア−マシウテイカル・インダストリアル・カンパニイ・リミテツド セフアロスポリン誘導体の製造方法
US4708956A (en) * 1985-12-12 1987-11-24 Kyowa Hakko Kogyo Co., Ltd. 3-position halogenated cephalosporin analogs and pharmaceutical compositions

Also Published As

Publication number Publication date
KR0135979B1 (ko) 1998-04-25
IL90269A0 (en) 1989-12-15
IL90269A (en) 1994-02-27
JPH0215078A (ja) 1990-01-18
EP0341991A3 (en) 1991-08-28
HUT50350A (en) 1990-01-29
HU203761B (en) 1991-09-30
EP0341991A2 (en) 1989-11-15

Similar Documents

Publication Publication Date Title
KR840008014A (ko) 오메프라졸염의 제조방법
KR840000528A (ko) 비스-트리아졸 유도체의 제조방법
ES8606262A1 (es) Procedimiento para preparar derivados de pleuromutilina
KR860003249A (ko) 피록시캄 1수화물의 제조 방법
KR830003478A (ko) 6-N-프로필-8α-메톡시메틸 또는 메틸메르캅토메틸 에르골린 유도체의 제조방법
BR8703747A (pt) Processo de producao de composicao aquosa espessada
KR890007730A (ko) 허혈성 심질환 치료제
KR880012604A (ko) (1r,5s,6s )-2-치환 티오-6[(r)-1-히드록시에틸]-1-메틸-카바페넴-3-카복실산 유도체
KR870001216A (ko) 3-프로페닐 세팔로스포린 용매화물
AR248407A1 (es) Un procedimiento para la preparacion de la forma monohidratada cristalina de una 1-carbacefalosporina.
KR890017259A (ko) 모액으로부터의 항생물질 회수방법 및 그의 약학적으로 허용할 수 있는 신규한 염
ES2028004T3 (es) Procedimiento para la recuperacion del rodio de las soluciones acuosas que contienen unas combinaciones complejas del rodio.
KR890008136A (ko) 항균성 9-데옥소-9a-알릴 및 프로파길-9a-아자-9a-호모에리트로 마이신 A 유도체
KR930700097A (ko) 수성 현탁액제의 제조방법
SE8701592L (sv) Farmaceutisk komposition som innehaller ett organiskt zinkkomplex samt forfarande for framstellning av den aktiva substansen
GB1318478A (en) Cephalexin salts
KR890003755A (ko) 7- (2- 메틸- 4- 아미노피롤리디닐)나프티리딘 및 퀴놀린 화합물
IL66473A0 (en) Aminoglycoside derivatives,their production and pharmaceutical compositions containing them
FI98814B (fi) Menetelmä puhtaan kaptopriilin valmistamiseksi
ES8603434A1 (es) Un procedimiento para la produccion del 1, 2, 4-triazolilpropanol
DE3068259D1 (en) Directly injectable aqueous solutions of the alkali salts of canrenoic acid and of furosemide, and process for their production
KR870002112A (ko) 벤조티아졸 술펜 아미드의 제조방법
KR880012585A (ko) 2-티에닐옥시아세트산 유도체, 이의 제조방법 및 이를 함유하는 약제
KR890003725A (ko) 아민유도체 및 이의 염, 이의 제조방법 및 이를 함유하는 궤양치료제
GB778148A (en) Stable neomycin compositions for oral administration

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee